Concepedia

Author

Nino Lomtadze

National Center for Tuberculosis and Lung DiseaseORCID

Also Known As

N Lomtadze, N. Lomtadze, Nino Lomtadze

35

Publications

645

Citations

11

H-Index

7

Concepts

All Affiliations

National Center for Tuberculosis and Lung DiseaseEmory UniversityMédecins Sans FrontièresHarvard UniversityPartners In Health
NL

About

Nino Lomtadze is an author at National Center for Tuberculosis and Lung Disease specializing in medicine, tuberculosis, and tuberculosis prevention.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

262

2

Tuberculosis

2

2

262

3

Drug Resistance

1

1

134

4

Antimicrobial Resistance

1

1

134

5

Pharmacotherapy

1

1

134

Nino Lomtadze

×

12

Publications

604

Citations

11

H-Index

YearCitations

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn,

The Lancet

2022

134

High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial

Nestan Tukvadze, Ekaterina Sanikidze, Maia Kipiani,

American Journal of Clinical Nutrition

2015

128

Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.

Nino Lomtadze, Rusudan Aspindzelashvili, Marina Janjgava,

PubMed

2009

120

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis

Nino Lomtadze, Lali Kupreishvili, Archil Salakaia,

PLoS ONE

2013

71

Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries

Lorenzo Guglielmetti, Catherine Hewison, Zaza Avaliani,

The International Journal of Tuberculosis and Lung Disease

2017

40

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

Gabriela B. Gomez, Mariana Siapka, Francesca Conradie,

BMJ Open

2021

29

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

Oleksandr Korotych, Jay Achar, Elmira Gurbanova,

The Lancet Infectious Diseases

2024

19

Long-term Follow-up Reveals High Posttreatment Mortality Rate Among Patients With Extensively Drug-Resistant Tuberculosis in the Country of Georgia

Melanie Frank, Natalia Adamashvili, Nino Lomtadze,

Open Forum Infectious Diseases

2019

16

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs

Ismat Lotia‐Farrukh, Nathalie Lachenal, Malik M Adenov,

Clinical Infectious Diseases

2023

14

Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs

Tea Madzgharashvili, Argita D. Salindri, Matthew J. Magee,

Journal of the Pediatric Infectious Diseases Society

2020

12

Page 1